ARDX
Ardelyx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.78
+1.89%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 14.42x
- P/E 2028E
- 4.61x
- P/S forward
- 1.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.55x
- Price / sales
- 2.16x
- Price / cash flow
- -56.35x
Enterprise value
- Enterprise value
- $950.3M
- EV / sales
- 2.11x
- EV / EBITDA
- -39.96x
- EV / EBIT
- -26.81x
- Market cap
- $975.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026